🧠 Parkinson's Digest Give Feedback
  • All
  • Research
  • Trials
  • News
How Does STN-DBS Influence Emotional Conflict Decision in Parkinson's Disease: a EEG Study
Trial N/A Completed May 31, 2016
Virtual Reality Effects on Functional Capacity and Quality of Life of People With Parkinson's Disease
Trial N/A Completed May 31, 2016
A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients
Trial Phase 1 Completed May 22, 2016
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Trial Phase 4 Completed May 19, 2016
Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures
Trial N/A Unknown May 18, 2016
Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa
Trial Phase 1 Completed May 18, 2016
Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease
Trial Phase 4 Unknown May 17, 2016
Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of BIA 3-202
Trial Phase 1 Completed May 15, 2016
Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites
Trial Phase 1 Completed May 12, 2016
Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202
Trial Phase 1 Completed May 12, 2016
High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's Disease
Trial Phase 2 Completed May 11, 2016
Resistance Versus Balance Training in Parkinson's Disease
Trial N/A Completed May 11, 2016
A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease
Trial Phase 1 Completed May 5, 2016
Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)
Trial Phase 1 Completed May 4, 2016
Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)
Trial Phase 1 Completed May 4, 2016
Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202
Trial Phase 1 Completed May 4, 2016
Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)
Trial N/A Completed May 3, 2016
Automated Telehealth Diagnostics for Remote Parkinson Monitoring
Trial N/A Completed April 27, 2016
Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison
Trial N/A Unknown April 26, 2016
Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism
Trial Phase 2 Completed April 24, 2016
Previous Next

Parkinson's Digest provides access to the latest Parkinson's disease news, research, and clinical trials.

Feedback | Privacy Policy | Source Code

Created by Brian Gaudino. Data sourced from ClinicalTrials.gov, PubMed, and other public sources.

Parkinson's Digest is provided for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.

© 2026 Parkinson's Digest